InvestorsHub Logo
Followers 46
Posts 1362
Boards Moderated 0
Alias Born 08/09/2015

Re: mrplmer post# 177968

Wednesday, 01/09/2019 9:09:53 AM

Wednesday, January 09, 2019 9:09:53 AM

Post# of 460683
Mrplmer: Thank you for this link dated Jan 8th:

https://rettsyndromenews.com/2019/01/08/phase-2-trial-anavex-2-73-rett-syndrome/

Dr. Kaufmann’s prominence relative to Rett research and investigations of treatments for Rett Syndrome is indisputable. For example, this article says:

“Anavex recently appointed Walter E. Kaufmann, MD, as chief medical officer of the company. Kaufmann was the founder and leader of RettSearch, the international consortium of Rett syndrome clinical researchers, and co-author of the current diagnostic guidelines for the disorder.

He currently leads the Rett Syndrome Molecular Biomarkers Working Group for the International Rett Syndrome Foundation and the Rett Syndrome Behaviour Questionnaire Working Group.”



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News